ArticleFrontiers in microbiology2023
Prevalence and antimicrobial resistance profiles of
Article in Frontiers in microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.
- ManagingMolecules (Basel, Switzerland) · 2025Pooled it
- The Integrative and Conjugative Element ICEThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2026Article
- Occurrence and Antibiotic Resistance Risk Burden ofAntibiotics (Basel, Switzerland) · 2025Article
- Seasonal prevalence and antimicrobial resistance profiles inItalian journal of food safety · 2025Article
- Draft genome sequences of 12Microbiology resource announcements · 2025Article
- Genomic Insight intoPathogens (Basel, Switzerland) · 2025Article
- A review on the ecological niche and functional properties of enterococci in health promotion.Current research in food science · 2025Review
- Prevalence ofFoods (Basel, Switzerland) · 2024Article
- Antibiotic Resistance in Vibrio Bacteria Associated with Red Spotting Disease in Sea UrchinMicroorganisms · 2024Article
- Assessment of Vibrionaceae prevalence in seafood from Qidong market and analysis of Vibrio parahaemolyticus strains.PloS one · 2024Article
- Spotlight on the epidemiology and antimicrobial susceptibility profiles ofFuture microbiology · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Shrimp is one of the most consumed seafood products globally. Antimicrobial drugs play an integral role in disease mitigation in aquaculture settings, but their prevalent use raises public health concerns on the emergence and spread of antimicrobial resistant microorganisms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.